ICU Care of the Solid Organ Transplant Recipient

  • Matthew R. Lammi
  • Jnanesh Thacker
  • Namrata Patel


After studying this chapter, you should be able to Identify and approach the management of perioperative complications after solid organ transplantation. Recognize the role of immunosuppressive therapy in allograft preservation as well as patient toxicity. Discuss the evaluation and management of posttransplant organ rejection. Recognize the broad spectrum of infections that occur in this immunocompromised patient population. Describe the prophylaxis and treatment of infections after solid organ transplantation.


Human Leukocyte Antigen Idiopathic Pulmonary Fibrosis West Nile Virus Acute Rejection Lung Transplant Recipient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Murray JE, Merrill JP, Harrison JH, et al. Renal homotransplantation in identical twins. Surg Forum. 1955;6:432-436.Google Scholar
  2. 2.
    Moris PJ. Transplantation – a medical miracle of the 20th century. N Eng J Med. 2004;351(26):2678-2680.CrossRefGoogle Scholar
  3. 3.
    Organ Procurement and Transplantation Network.; 2009 Accessed 14.04.09.
  4. 4.
    Steinman TI, Becker BN, Frost AE, et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation. 2001;71:1189-1204.PubMedCrossRefGoogle Scholar
  5. 5.
    Knoll G, Cockfield S, Blydt-Hansen T, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173:S1-S25.PubMedCrossRefGoogle Scholar
  6. 6.
    Krasko A, Deshpande K, Bonvine S. Liver failure, transplantation, and critical care. Crit Care Clin. 2003;19:155-183.PubMedCrossRefGoogle Scholar
  7. 7.
    Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797.PubMedCrossRefGoogle Scholar
  8. 8.
    Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8:851-858.PubMedCrossRefGoogle Scholar
  9. 9.
    Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates – 2006. J Heart Lung Transplant. 2006;25:1024-1042.PubMedCrossRefGoogle Scholar
  10. 10.
    Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update–a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25:745-755.PubMedCrossRefGoogle Scholar
  11. 11.
    Gilks WR, Bradley BA, Gore SM. Substantial benefits of tissue matching in renal transplantation. Transplantation. 1987;43:669-674.PubMedCrossRefGoogle Scholar
  12. 12.
    Studer SM, Orens JB. Cadaveric donor selection and management. Respir Care Clin N Am. 2004;10:1-9.CrossRefGoogle Scholar
  13. 13.
    Najarian J. Kidney transplantation: personal reflections. In: Gruessner RW, Benedetti E, eds. Living Donor Organ Transplantation. 1st ed. USA: McGraw-Hill; 2008:131-133.Google Scholar
  14. 14.
    Broelsch C, Nadalin S, Malago M. Personal reflections and history of liver transplantation. In: Gruessner RW, Benedetti E, eds. Living Donor Organ Transplantation. 1st ed. USA: McGraw-Hill; 2008:438-442.Google Scholar
  15. 15.
    Markmann JF, Yeh H, Naji A, Olthoff KM, Shaked A, Barker CF. Abdominal transplantations. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston Textbook of Surgery. 18th ed. Philadelphia: Saunders; 2008:692-733.Google Scholar
  16. 16.
    Salerno C, Verrier E. Heart transplantation. In: Kaiser LR, Kron IL, Spray TL, eds. Mastery of Cardiothoracic Surgery. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007:579-586.Google Scholar
  17. 17.
    Davies D. Lung transplantation. In: Kaiser LR, Kron IL, Spray TL, eds. Mastery of Cardiothoracic Surgery. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007:194-203.Google Scholar
  18. 18.
    Sadaghar H, Chelluri M, Bowles SA, Shapiro R. Outcome of renal transplant recipients in the ICU. Chest. 1995;107:1402-1405.CrossRefGoogle Scholar
  19. 19.
    Irish WD, McCollum DA, Tesi RJ, Owen AB. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol. 2003;14:2967-2974.PubMedCrossRefGoogle Scholar
  20. 20.
    Lechevallier E, Dussol B, Luccioni A, et al. Posttransplantation acute tubular necrosis: risk factors and implications for graft survival. Am J Kidney Dis. 1998;32:984-991.PubMedCrossRefGoogle Scholar
  21. 21.
    Humar A, Matas AJ. Surgical complications after kidney transplantation. Semin Dial. 2005;18:505-510.PubMedCrossRefGoogle Scholar
  22. 22.
    Martin P, Hugo RR. Liver transplantation. In: Feldman M, Friedman LS, Lawrence J, Brandt LJ, eds. Feldman: Sleisenger and Fordtrans’s Gastointestinal and Liver Disease. 8th ed. Philadelphia: Saunders Elsevier; 2006:2035-2056.Google Scholar
  23. 23.
    Faenza S, Bernardi E, Cuppini A, et al. Intensive care complications in liver and multivesceral transplantation. Transplantation Proc. 2005;37:2618-2621.CrossRefGoogle Scholar
  24. 24.
    Chacko P, Philip S. Emergency department presentation of heart transplant recipients with acute heart failure. Heart Fail Clin. 2009;5:129-143.PubMedCrossRefGoogle Scholar
  25. 25.
    Shanewise J. Cardiac transplantation. Anesth Clin N Am. 2004;22:753-765.CrossRefGoogle Scholar
  26. 26.
    Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005;24:1454-1459.PubMedCrossRefGoogle Scholar
  27. 27.
    Meade MO, Granton JT, Matte-Martyn A, et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med. 2003;167:1483-1489.PubMedCrossRefGoogle Scholar
  28. 28.
    Pilcher DV, Scheinkestel CD, Snell GI, et al. High central venous pressure is associated with prolonged mechanical ventilation and increased mortality after lung transplantation. J Thorac Cardiovasc Surg. 2005;129:912-918.PubMedCrossRefGoogle Scholar
  29. 29.
    Goudarzi B, Bonvino S. Critical care issues in lung and heart transplantation. Crit Care Clin. 2003;19:209-231.PubMedCrossRefGoogle Scholar
  30. 30.
    Ferdinande P, Bruyninckx F, Van Raemdonck D, et al. Phrenic nerve dysfunction after heart-lung and lung transplantation. J Heart Lung Transplant. 2004;23:105-109.PubMedCrossRefGoogle Scholar
  31. 31.
    Sheridan PH, Cheriyan H, Doud J, et al. Incidence of phrenic neuropathy after isolated lung transplantation. J Heart Lung Transplant. 1995;14:684-691.PubMedGoogle Scholar
  32. 32.
    Nielsen TD, Bahnson T, Davis RD, Palmer SM. Atrial fibrillation after pulmonary transplant. Chest. 2004;126:496-500.PubMedCrossRefGoogle Scholar
  33. 33.
    Sykes M. Transplant immunology. In: Goldman L, Ausiello D, eds. Goldman: Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier; 2007:277-282.Google Scholar
  34. 34.
    Halloran P. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351:2715-2729.PubMedCrossRefGoogle Scholar
  35. 35.
    Wiesner R, Rabkin J, Klintmalm G, et al. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transpl. 2001;7:442-450.PubMedCrossRefGoogle Scholar
  36. 36.
    Groetzner J, Kur F, Spelsberg F, et al. Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant. 2004;23:632-638.PubMedCrossRefGoogle Scholar
  37. 37.
    Brock MV, Borja MC, Ferber L, Orens JB. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. J Heart Lung Transplant. 2001;20:1274-1281.CrossRefGoogle Scholar
  38. 38.
    Moll S, Pascual M. Humoral rejection of organ allografts. Am J Transplant. 2005;5:2611-2618.PubMedCrossRefGoogle Scholar
  39. 39.
    Michaels PJ, Espejo ML, Kobashigawa J, et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences, and relationship to transplant coronary artery disease. J Heart Lung Transplant. 2003;22:58-69.PubMedCrossRefGoogle Scholar
  40. 40.
    Mills RM, Naftel DC, Kirklin JK, et al. Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database. J Heart Lung Transplant. 1997;16:813-821.PubMedGoogle Scholar
  41. 41.
    Scott CD, Dark JH, McComb JM. Arrhythmias after cardiac transplantation. Am J Cardiol. 1992;70:1061-1063.PubMedCrossRefGoogle Scholar
  42. 42.
    Frost AE, Jammal CT, Cagle PT. Hyperacute rejection following lung transplantation. Chest. 1996;110:559-562.PubMedCrossRefGoogle Scholar
  43. 43.
    Rocha PN, Butterly DW, Greenberg A, Reddan DN. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation. 2003;75:1490-1495.PubMedCrossRefGoogle Scholar
  44. 44.
    Gray D, Shepherd H, Daar A, et al. Oral versus intravenous high dose steroid treatment of renal allograft rejection. Lancet. 1978;1:117-118.PubMedCrossRefGoogle Scholar
  45. 45.
    Green M, Avery R. Introduction to the Guidelines. Am J Transpl. 2004;4(suppl 10):6-9.Google Scholar
  46. 46.
    Trzeciak S, Sharer R, Piper D, et al. Infections and severe sepsis in solid-organ transplant patients admitted from a university-based ED. Am J Emerg Med. 2004;22:530-533.PubMedCrossRefGoogle Scholar
  47. 47.
    Fishman JA. Infection in solid organ transplant patients. NEJM. 2007;357:2601-2614.PubMedCrossRefGoogle Scholar
  48. 48.
    Green M, Avery R. Fungal infections. Am J Transpl. 2004;4(suppl 10):110-134.Google Scholar
  49. 49.
    Green M, Avery R. Cytomegalovirus. Am J Transpl. 2004;4(suppl 10):51-58.Google Scholar
  50. 50.
    van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis. 2001;33(suppl 1):33-37.Google Scholar
  51. 51.
    Bouza E. Evaluation fever of unknown origin in solid organ transplant recipients. Infect Dis Clin North Am. 2007;21:1033-1054.PubMedCrossRefGoogle Scholar
  52. 52.
    Lehto JT, Koskinen PK, Anttila VJ, et al. Bronchoscopy in the diagnosis and surveillance of respiratory infections in lung and heart-lung transplant recipients. Transpl Int. 2005;18:562-571.PubMedCrossRefGoogle Scholar
  53. 53.
    Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.PubMedCrossRefGoogle Scholar
  54. 54.
    Green M, Avery R. Pneumocystis jiroveci (formerly Pneumocystis carinii). Am J Transpl. 2004;4(suppl 10):135-141.Google Scholar
  55. 55.
    Andreone P, Gramenzi A, Lorenzini S. Posttransplantation lymphopoliferative disorders. Arch Intern Med. 2003;163:1997-2004.PubMedCrossRefGoogle Scholar
  56. 56.
    Green M, Avery R. Epstein-Barr virus and lymphoproliferative disorders after transplantation. Am J Transpl. 2004;4(suppl 10):59-65.Google Scholar
  57. 57.
    Triulzi DJ. Specialized transfusion support solid organ transplantation. Curr Opin Hematol. 2002;9:527-532.PubMedCrossRefGoogle Scholar

Additional Reading

  1. Halloran P. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351:2715-2729.PubMedCrossRefGoogle Scholar
  2. Fishman JA. Infection in solid organ transplant patients. N Engl J Med. 2007;357:2601-2614.PubMedCrossRefGoogle Scholar
  3. Andreone P, Gramenzi A, Lorenzini S. Post-transplantation lymphopoliferative disorders. Arch Intern Med. 2003;163:1997-2004.PubMedCrossRefGoogle Scholar
  4. Triulzi DJ. Specialized transfusion support solid organ transplantation. Curr Opin Hematol. 2002;9:527-532.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Matthew R. Lammi
    • 1
  • Jnanesh Thacker
    • 2
  • Namrata Patel
    • 3
  1. 1.Temple University HospitalPhiladelphiaUSA
  2. 2.Division of Cardiopulmonary TransplantationTemple UniversityPhiladelphiaUSA
  3. 3.Division of Pulmonary and Critical Care MedicineTemple University School of MedicinePhiladelphiaUSA

Personalised recommendations